This plant is where I worked from 1979 to 1992 in QA and manufacturing.
This facility was built by Abbott Laboratories, became part of Hospira in 2006 and then sold to Pfizer.
The main facility is not damaged per se, however the automated high rise warehouse was flattened.
The 14 story tall robotic warehouse had over 40,000 pallet spaces. The warehouse floor was laid down and had to be level to within 4mm.
I helped execute the validation of the computer controlled system that kept quarantine and finished goods next to each other, only separated by the computer.
This warehouse was also a major distribution center for the east coast.
I’m glad for your detail that just the warehouse, not the manufacturing plant was damaged. Rebuilding the plant to FDA cleanliness standards would be a major project which the paper pushers could slow down further. Here the problem sounds mostly like loss of significant inventory and that their supply chain distribution for replacement production will be less efficient until the high tech warehousing can be restored. There has been a significant shortage of local anesthetics in US for over a year, the predicted end of which has kept being pushed back to a year ahead or now. Pfizer is one of the major manufacturers that have been affected and it sounds like this warehouse loss is likely to make the shortage worse. I’ve finally read admissions somewhere that repurposing Pfizer resources away from prior priorities to covid vaccine production is what caused the shortage. It’s kind of hard as a Dermatologist to biopsy or remove skin lesions without local anesthetics, yet I’ve come close to running out of that a couple times the past year. This is apt to make the problem worse.